The Influence of Brexit on Operations of Global Companies in the Pharmaceutical Industry: the Cases of GlaxoSmithKline and AstraZeneca
Theoretical aspects of Brexit. Internal and external environment of global companies in the pharmaceutical industry. Impact of Brexit on operations of global companies in the pharmaceutical industry. Landscape of the pharmaceutical industry in the UK.
| Рубрика | Медицина |
| Вид | дипломная работа |
| Язык | английский |
| Дата добавления | 21.09.2018 |
| Размер файла | 672,3 K |
Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже
Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.
42. ABPI Members List. (n.d.). Retrieved from http://www.abpi.org.uk/membership/abpi-members-list/
43. Annex 7 WHO guidelines on transfer of technology in ... (n.d.). Retrieved from http://www.who.int/medicines/areas/quality_safety/quality_assurance/TransferTechnologyPharmaceuticalManufacturingTRS961Annex7.pdf
44. Annex 9 Guidelines on packaging for pharmaceutical products. (n.d.). Retrieved from http://www.who.int/medicines/areas/quality_safety/quality_assurance/GuidelinesPackagingPharmaceuticalProductsTRS902Annex9.pdf
45. Annual report 2017. (n.d.). Retrieved from https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/
46. AstraZeneca plc. (2017, February 20). Retrieved from https://accesstomedicineindex.org/report-cards/astrazeneca-plc/
47. Biotech company wins Horizon 2020 funding | H2020 News. (2017, June 19). Retrieved from http://www.horizon2020projects.com/il-biotechnology/biotech-company-wins-horizon-2020-funding/
48. Brexit and the Pharmaceutical Industry - Europe Economics. (2016). Retrieved from http://www.europe-economics.com/attachments/brexit_and_the_pharmaceutical_industry_1469784623.pdf
49. Brexit - an Impact Analysis - KPMG | US. (n.d.). Retrieved from https://home.kpmg.com/content/dam/kpmg/de/pdf/Themen/2017/brexit-strategy-impact-analysis-india-2-2017-KPMG.pdf
50. CollegeGrad. (n.d.). Retrieved from https://collegegrad.com/industries/pharmaceutical-and-medicine-manufacturing
51. CRA The impact of a change in the UK relationship ... - EFPIA. (n.d.). Retrieved from https://www.efpia.com/
52. Dominici. (2017). Retrieved from https://www.researchgate.net/publication/315791997
53. Drug Development Database| Pharma R&D| Pharmaprojects. (n.d.).
54. EDUCATION, B. P. (2017). ACCA APPROVED - P3 BUSINESS ANALYSIS (SEPTEMBER 2017 TO JUNE 2018 EXAMS). S.l.: BECKER PROFESSIONAL EDUCA.
55. Frascati manual 2015: Guidelines for collecting and reporting data on research and experimental development. (2015). Paris: OECD Publishing.
56. GlaxoSmithKline lays plans to secure post-Brexit supply chain. (n.d.). Retrieved from https://www.ft.com/content/02c37d0e-9b85-11e6-b8c6-568a43813464
57. GSK: UK still 'attractive' post Brexit as it invests Ј275m. (2016, July 27). Retrieved from http://www.bbc.com/news/business-36901027
58. Less is more with advanced technologies in manufacturing. (2015, October 07). Retrieved from https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/less-is-more-with-advanced-technologies-in-manufacturing/
59. Life Sciences definition. (n.d.). Retrieved from http://www.parliament.uk/
60. Life sciences: Sector Deal. (n.d.). Retrieved from https://www.gov.uk/government/publications/life-sciences-sector-deal
61. Number on the UK pharmaceutical industry. (n.d.). Retrieved from Euromonitor.
62. OECD. (n.d.). BERD, HERD, GERD, GDP. Retrieved from http://stats.oecd.org/
63. Pharmaceutical firms trigger contingency plans for a no-deal Brexit. (2017, November 16). Retrieved from https://www.economist.com/news/britain/21731409-industry-long-production-timelines-cannot-afford-wait-any-longer-pharmaceutical-firms
64. Pharmaceuticals Sector Fiche (16.12.2011) - Europa. (n.d.). Retrieved from http://trade.ec.europa.eu/doclib/docs/2012/january/tradoc_148988.pdf
65. PricewaterhouseCoopers. (n.d.). The impact on Pharma & Life Sciences. Retrieved from https://www.pwc.nl/en/eu-referendum/brexit-monitor/the-impact-on-pharma-life-sciences.html
66. Report 2016. (n.d.). Retrieved from http://www.evaluategroup.com/public/Reports/EvaluatePharma-World-Preview-2016.aspx
67. Pharmaceutical R&D Global Spending Trends -Prescouter - Custom Intelligence, On-Demand. Retrieved from https://prescouter.com/2016/12/pharma-research-development-spending-trends/
68. Statistical bulletin:Gross domestic expenditure on research and development, UK: 2016. (n.d.). Retrieved from https://www.ons.gov.uk/economy/governmentpublicsectorandtaxes/researchanddevelopmentexpenditure/bulletins/ukgrossdomesticexpenditureonresearchanddevelopment/2016
69. The Dowling Review of Business-University Research ... (n.d.). Retrieved from https://www.raeng.org.uk/publications/reports/the-dowling-review-of-business-university-research
70. P. (n.d.). The economic contribution of the UK Life Sciences industry. Retrieved from https://www.pwc.co.uk/industries/pharmaceuticals-life-sciences/economic-contribution-of-uk-life-sciences-industry.html
71. The pharmaceutical industry and global health: Facts & figures. (n.d.). Retrieved from https://www.ifpma.org/resource-centre/the-pharmaceutical-industry-and-global-health/
72. The Pharmaceutical Industry in Figures - EFPIA Homepage. (n.d.). Retrieved from https://www.efpia.eu/
73. The role of EU funding in UK research and innovation. (n.d.). Retrieved from https://royalsociety.org/~/media/policy/Publications/2017/2017-05-technopolis-role-of-EU-funding-report.PDF
74. What science can do Annual Report & Form 20-F Information 2017. (n.d.). Retrieved from https://www.astrazeneca.com/investor-relations/annual-reports/annual-report-2017.html
75. Annual report 2017. (n.d.). Retrieved from https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/
76. Annual report 2016. (n.d.). Retrieved from https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2016/
77. https://www.theguardian.com - EU referendum to take place on 23 June, David Cameron confirms
78. Clariton Solicitors Limited- https://www.clarionsolicitors.com/blog/uks-pharmaceutical-industry-and-brexit-what
79. Press Release by EvaluateGroup, Russel at el, 1999 - https://www.evaluategroup.com/secure/Login.aspx?ReturnUrl=%2fUniversal%2fView.aspx%3ftype%3dStory%26id%3d8553&CanUseGuest=True&CookieTest=True
80. https://dictionary.cambridge.org/dictionary/english/soft-brexit
81. https//csef.ru
82. Zephyr DataBase”
Appendixes
“Appendix 1. Elements of a comprehensive drug law
|
General provisions |
Title* Purposes* Territorial extent Application of other laws Definitions* |
|
|
Control of availability and marketing |
Drug registration* National essential medicines list/national formulary Scheduling prescription, and dispensing authority* Labeling* Generic labeling, manufacturing, and substitution Pharmacovigilance Information and advertising* Public education Imposition of fees Price control Special products (herbal medicines, medicines for clinical trials, orphan drugs) |
|
|
Control of supply mechanisms |
Importation of medicines* Exportation of medicines* Controls, incentives, disincentives for local manufacture Control of distribution, supply, storage, and sale* |
|
|
Drug control administration |
Organization and function* Appeals against decisions of the drug control authority* |
|
|
Powers of enforcement |
Prohibition of specified activities* Penalties for each offense based on magnitude and occurrence* Legal procedures for offenses* |
|
|
Powers to make rules and regulations |
Who has authority* Under which circumstances* |
|
|
Repeals and transitional provisions |
Repeal of sections of existing laws in conflict with the act Transitional period to implementation* |
|
|
H. Exemptions from provisions of the law* |
Adapted from WHO 1998b, 1999c. - https://www.msh.org/sites/msh.org/files/mds3-ch06-legislation-mar2012.pdf “
Размещено на Allbest.ru
Подобные документы
Ensuring access to health care (on the example, Novo Nordisk). Comparison of of different companies: sales growth and margin, ROE, returns stock price. Relationship between ATM index and stock returns. Strategic pillars of the pharmaceutical companies.
презентация [935,7 K], добавлен 18.10.2015Structure of a clinical term. The suffixes and prefixes. The final combining forms partaining to diagnostic methods, therapy, pathology, surgical interventions. Pharmaceutical term structure. The forms of medicines. Chemical, botanical terminology.
методичка [458,1 K], добавлен 29.03.2012The history of the public health system in Kazakhstan. Human resources, the capacity of organizations and reform of the health system. Pharmaceutical market in the country. Priority sectors of the medical equipment market. Medical education and science.
презентация [987,7 K], добавлен 04.02.2015Classification of the resistance. External and internal barnry protecting the human body from pathological factors of the environment. The chemical composition of the blood, its role and significance. Influence the age on individual reactivity progeria.
презентация [4,5 M], добавлен 17.10.2016The development of modern medicine. The creation of internal organs, implants. The use of modern orthopaedics mechanical devices. The replacement of lost parts of the human body by means of surgical operations. Bridge denture. The use of prostheses.
презентация [5,0 M], добавлен 31.05.2016Definition, pathophysiology, aetiologies (structural lesions, herniation syndromes, metabolic disturbances) of coma. Physical examination and investigations. Differential diagnosis - the pseudocomas. Prognostic signs in coma from global cerebral ischemia.
презентация [875,4 K], добавлен 24.03.2015Analysis of factors affecting the health and human disease. Determination of the risk factors for health (Genetic Factors, State of the Environment, Medical care, living conditions). A healthy lifestyle is seen as the basis for disease prevention.
презентация [1,8 M], добавлен 24.05.2012Areas with significant numbers of malaria cases: Africa, the Middle East, India, Southeast Asia, South America, Central America and parts of the Caribbean. Etiology, symptoms and diagnosis of the disease, methods of treatment and antimalarial immunity.
презентация [286,9 K], добавлен 02.10.2012The main clinical manifestation of intestinal lymphangiectasia is a syndrome of malabsorption: diarrhea, vomiting, abdominal pain. In some cases, steatorrhea of varying severity occurs. Cystic cavity, deforming the villus. Hematoxylin and eosin stein.
статья [20,9 K], добавлен 29.09.2015The concept and the internal structure of the lungs, the main components and their interaction. Functional features of the lungs in the human body, their relationship with other anatomical systems. Existing pathology of respiratory organ and control.
презентация [2,5 M], добавлен 12.02.2015
